NASDAQ Companies

– Industry-leading PK Activator Franchise Has Demonstrated Clinical Efficacy in Four Hematological Diseases, Including New Positive Phase 3 Data in […]

– Initial Data from the Ongoing Phase 2 Trial in Combination with the Antibody-Drug Conjugate (ADC) Sacituzumab Govitecan (SG) Suggest […]

SAN MATEO, Calif. and SINGAPORE, Jan. 08, 2024 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (NASDAQ: ASLN) (“ASLAN” or the “Company”), announced […]

STAMFORD, Conn., Jan. 08, 2024 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe […]

IRVINE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — CalAmp (Nasdaq: CAMP), a connected intelligence company helping people and organizations improve […]

First Patient Dosed and Successfully Engrafted in BEACON Phase 1/2 Trial of BEAM-101 in Patients with Severe Sickle Cell Disease; […]

JERSEY CITY, N.J., Jan. 08, 2024 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, […]

Reports preliminary fiscal 2023 net new center openings at high end of previous outlookExpects remaining fiscal 2023 financial results within […]

WILMINGTON, Del., Jan. 08, 2024 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development […]

LOS ANGELES, Jan. 08, 2024 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic […]